At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
Lexicon Pharmaceuticals ( (LXRX)) has issued an update. On November 6, 2025, Lexicon Pharmaceuticals filed a prospectus supplement related to its Open Market Sale Agreement with Jefferies LLC, ...
This is a comprehensive data solution designed to streamline the collection, transformation, and analysis of financial data related to gold as a commodity for investment portfolio management. A ...
Supporting Lexicon Pharmaceuticals’ decision to advance the non-opioid analgesic pilavapadin into late-stage development—despite a topline miss in March—is an “improving” regulatory environment for ...
If you’d like an LLM to act more like a partner than a tool, Databot is an experimental alternative to querychat that also works in both R and Python. Databot is designed to analyze data you’ve ...
Lexicon has pivoted back to a research-driven biotech model, abandoning internal drug marketing to focus on clinical development and out-licensing. Pilavapadin's upcoming Phase II readout is critical, ...
Communications surveillance plays a critical role in ensuring firms detect and prevent market abuse, insider trading, and other forms of misconduct. A recent update from Regtech SteelEye, a compliance ...
Have you ever found yourself wrestling with Excel formulas, wishing for a more powerful tool to handle your data? Or maybe you’ve heard the buzz about Python in Excel and wondered if it’s truly the ...
What if you could turn Excel into a powerhouse for advanced data analysis and automation in just a few clicks? Imagine effortlessly cleaning messy datasets, running complex calculations, or generating ...
The first script, cot_collector.py, is designed to scrape and parse COT data from the CFTC website, specifically from the Chicago Mercantile Exchange (CME) futures reports. Here's how it operates: ...
Mike Exton, Chief Executive Officer, highlighted a pivotal exclusive license agreement with Novo Nordisk for LX9851, stating "this agreement grants Novo an exclusive worldwide license to develop, ...